Clinical trial
Safety Study of Individualised Radiation Dose Determination for Lung Cancer…
NCT00181545 · Maastricht Radiation Oncology, Other · Completed
Key facts
| NCT number | NCT00181545 |
|---|---|
| Title | Safety Study of Individualised Radiation Dose Determination for Lung Cancer Patients. |
| Official title | Individualised Radiation Dose Determination on Basis of Normal Tissue Dose Constraints in Patients With Non-Small-Cell Lung Cancer: A Phase I Study |
| Lead sponsor | Maastricht Radiation Oncology, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Non-Small-Cell Lung Carcinoma |
| Intervention type | Procedure |
| Interventions | escalation of dose (radiotherapy treatment) |
| Enrollment | 30 |
| Start date | Dec 1, 2004 |
| Primary completion | May 1, 2008 |
| Completion | May 1, 2008 |
| First posted | Sep 16, 2005 |
| Last update posted | Jun 30, 2009 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: